BTC $78,823.62 -1.11%
ETH $2,470.63 -0.41%
BNB $736.47 -1.13%
XRP $1.38 -1.94%
SOL $103.30 -2.37%
TRX $0.3338 -0.37%
DOGE $0.0890 +0.29%
ADA $0.2175 +0.09%
BCH $258.64 +1.32%
LINK $12.91 +5.67%
HYPE $85.23 -3.71%
AAVE $130.99 -1.88%
SUI $0.8057 +1.96%
XLM $0.1888 +2.71%
ZEC $1,157.58 -0.58%
BTC $78,823.62 -1.11%
ETH $2,470.63 -0.41%
BNB $736.47 -1.13%
XRP $1.38 -1.94%
SOL $103.30 -2.37%
TRX $0.3338 -0.37%
DOGE $0.0890 +0.29%
ADA $0.2175 +0.09%
BCH $258.64 +1.32%
LINK $12.91 +5.67%
HYPE $85.23 -3.71%
AAVE $130.99 -1.88%
SUI $0.8057 +1.96%
XLM $0.1888 +2.71%
ZEC $1,157.58 -0.58%

LIXTE Biotechnology, a publicly traded company in the U.S., has launched a cryptocurrency reserve strategy, planning to allocate 25% of its funds to BTC

2025-08-13 20:02:06

ChainCatcher news, Nasdaq-listed company LIXTE Biotechnology announced that its board has approved a strategic capital allocation plan to acquire cryptocurrency as part of the company's funds. The company's board also approved allocating 25% of the funds to cryptocurrency, including Bitcoin and other potential digital assets (as applicable).

Связанные теги
Связанные теги
app_icon
ChainCatcher Building the Web3 world with innovations.